Pharma 2020: Challenging Business Models
Pharmaceutical companies will need to forge collaborative partnerships and alliances with companies from other sectors in order to overcome the challenges facing the market in the wake of the financial crisis. This is the main conclusion of the report “Pharma 2020: Challenging Business Models,” published by PricewaterhouseCoopers. The study takes a close look at current market trends forcing pharmaceuticals to pursue alliances and proposes a range of solutions to successfully address the current challenges facing the industry.
The report is available to download from PricewaterhouseCoopers’ website.
Explore posts in the same categories: Market & Industry reports